Bristol-Myers Squibb Co

NYSE : BMY

$59.75−1.27%

Financials

Balance sheet · full history

USD in millions · per-share amounts unscaled. Each period shows the value from the latest filing that prints it.

Reported line item	Dec 31, 2018Balance date	Dec 31, 2019Balance date	Dec 31, 2020Balance date	Dec 31, 2021Balance date	Dec 31, 2022Balance date	Dec 31, 2023Balance date	Dec 31, 2024Balance date	Dec 31, 2025Balance date

Balance sheet, full reported history for 0000014272. USD in millions · per-share amounts unscaled. Each period shows the value from the latest filing that prints it.
Reported line item	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025
Cash and cash equivalents	6,911	12,346	14,546	13,979	9,123	11,464	10,346	10,209
Marketable debt securities	1,848R	3,047	1,285	2,987	130	816	513	464
Receivables	5,747R	7,685	8,501	9,369	9,886	10,921	10,747	11,414
Inventories	1,195	4,293	2,074	2,095	2,339	2,662	2,557	2,690
Other current assets	2,015R	1,983	3,786	4,832	5,795	5,907	5,617	4,613
Total Current assets	17,716R	29,354	30,192	33,262	27,273	31,770	29,780	29,390
Property, plant and equipment	5,027	6,252	5,886	6,049	6,255	6,646	7,136	7,543
Goodwill	6,538	22,488	20,547	20,502	21,149	21,169	21,719	21,754
Other intangible assets	1,091	63,969	53,243	42,527	35,859	27,072	23,307	19,103
Deferred income taxes	815R	510	1,161	1,439	1,344	2,768	4,236	5,378
Marketable debt securities					0	364	320	396
Marketable debt securitiesno longer reported	1,775	767	433	0
Other non-current assets	2,024	6,604	7,019	5,535	4,940	5,370	6,105	6,474
Total Assets	34,986	129,944	118,481	109,314	96,820	95,159	92,603	90,038
Short-term debt obligations	1,703	3,346	2,340	4,948	4,264	3,119	2,046	2,261
Accounts payable	1,892	2,445	2,713	2,949	3,040	3,259	3,602	3,575
Other current liabilities	7,059	12,513	14,027	13,971	14,586	15,884	18,126	17,581
Total Current liabilities	10,654	18,304	19,080	21,868	21,890	22,262	23,774	23,417
Deferred income taxes	19	6,454	5,407	4,501	2,166	338	369	222
Long-term debt	5,646	43,387	48,336	39,605	35,056	36,653	47,603	42,850
Other non-current liabilities	4,540R	10,101	7,776	7,334	6,590	6,421	4,469	5,043
Total Liabilities	20,859	78,246	80,599	73,308	65,702	65,674	76,215	71,533
Commitments and Contingencies (Note 20)	—	—	—	—	—	—	—	—
Preferred stock, $2 convertible series, par value $1 per share: Authorized 10 million shares; issued and outstanding 2,510 in 2025 and 2,868 in 2024, liquidation value of $50 per share	0	0	0	0	0	0	0	0
Common stock, par value of $0.10 per share: Authorized 4.5 billion shares; 2.9 billion issued in 2025 and 2024					292	292	292	292
Common stock, par value of $0.10 per share: Authorized 4.5 billion shares; 2.9 billion issued in 2022 and 2021no longer reported	221	292	292	292	292
Capital in excess of par value of stock	2,081	43,709	44,325	44,361	45,165	45,684	46,024	46,387
Accumulated other comprehensive loss	(2,762)	(1,520)	(1,839)	(1,268)	(1,281)	(1,546)	(1,238)	(1,524)
Retained earnings	34,065	34,474	21,281	23,820	25,503	28,766	14,912	16,896
Less cost of treasury stock 887 million common shares in 2025 and 894 million common shares in 2024				(31,259)	(38,618)	(43,766)	(43,655)	(43,579)
Less cost of treasury stock 747 million common shares in 2021 and 679 million common shares in 2020no longer reported	(19,574)	(25,357)	(26,237)	(31,259)
Total BMS Shareholders Equity	14,031	51,598	37,822	35,946	31,061	29,430	16,335	18,473
Noncontrolling interest	96	100	60	60	57	55	53	33
Total Equity	14,127	51,698	37,882	36,006	31,118	29,485	16,388	18,506
Total Liabilities and Equity	34,986	129,944	118,481	109,314	96,820	95,159	92,603	90,038
Preferred stock, shares outstanding (in shares)						<0.01	<0.01	<0.01
Preferred Stock, Shares Outstandingno longer reported		<0.01	<0.01
Preferred stock, shares issued (in shares)						<0.01	<0.01	<0.01
Preferred Stock, Par or Stated Value Per Shareno longer reported		1.00	1.00
Preferred Stock, Shares Authorizedno longer reported		10	10
Preferred Stock, Shares Issuedno longer reported		<0.01	<0.01
Preferred Stock, Liquidation Preference Per Shareno longer reported		50.00	50.00
Common Stock, Par or Stated Value Per Shareno longer reported		0.10	0.10
Common Stock, Shares Authorizedno longer reported		4,500	4,500
Common Stock, Shares Issuedno longer reported		2,900	2,900
Treasury Stock, Sharesno longer reported		672	679

History starts FY2018, the period ended Dec 31, 2018 — the earliest period our structured-data source covers, not the company’s first year.

46 reported lines · 8 periods · values taken from the latest filing that prints each period.

R6 restated by the filer — hover for the figure as first reported.
italic12 from an earlier filing than the rest of the column.
no longer reported12 lines the filer stopped printing.
— the filer printed the line and left the period empty. An empty cell means the line was not printed at all; it is never a zero.

274 of 274 values link to the exact element in the filer’s own document.

Every line and every caption is the company’s own. Each period carries the value from the latest filing that prints it, which is why a restated period shows the restated number with the figure as first reported kept underneath.

Nothing on this table is computed by us: no fourth quarter, no growth rate, no margin. Marks describe the filer’s own restatements.